|Mr. Ross Bjella||Chairman & CEO||N/A||N/A||1962|
|Mr. Terrance Kurtenbach||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Christopher Breault||COO & Director||N/A||N/A||N/A|
|Michael Hamblett||Director of Investor Relations||N/A||N/A||N/A|
|Mr. James Barrow Esq.||Gen. Counsel and Director of Quality & Regulatory||N/A||N/A||N/A|
|Dr. Mark V. Smith||VP of Sales & Bus. Devel. and Director||N/A||N/A||N/A|
|Dr. Christopher Mirucki||Chief Medical Officer||N/A||N/A||N/A|
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers. The company develops, manufactures, and distributes custom cranial and craniofacial fixation screws for patients requiring the reconstruction of cranial and facial structures. It serves health systems, hospitals, sales representative, and surgeons, payors, and patients. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. The company was incorporated in 2005 and is based in Collinsville, Connecticut.
Kelyniam Global, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.